1. Home
  2. LIF vs LQDA Comparison

LIF vs LQDA Comparison

Compare LIF & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Life360 Inc.

LIF

Life360 Inc.

HOLD

Current Price

$40.00

Market Cap

3.5B

Sector

N/A

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$61.47

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIF
LQDA
Founded
2008
2004
Country
United States
United States
Employees
547
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.4B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
LIF
LQDA
Price
$40.00
$61.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
11
Target Price
$75.58
$41.00
AVG Volume (30 Days)
722.7K
1.6M
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
51.81
EPS
N/A
0.52
Revenue
N/A
$158,320,000.00
Revenue This Year
$36.21
$278.87
Revenue Next Year
$20.80
$57.13
P/E Ratio
$425.29
$118.31
Revenue Growth
N/A
1031.18
52 Week Low
$37.01
$11.85
52 Week High
$112.54
$62.30

Technical Indicators

Market Signals
Indicator
LIF
LQDA
Relative Strength Index (RSI) 43.89 80.46
Support Level $37.47 $31.23
Resistance Level $42.15 N/A
Average True Range (ATR) 2.10 3.75
MACD -0.26 1.28
Stochastic Oscillator 28.82 96.68

Price Performance

Historical Comparison
LIF
LQDA

About LIF Life360 Inc.

Life360 is the world's largest family focused social network, with nearly 100 million monthly active users. Security-conscious families use the Life360 app to track each other's whereabouts and to track the location of their pets and personal belongings. Life360 also offers a suite of additional security features, such as driver safety monitoring, roadside assistance, and emergency dispatching. In the US, the Life360 app regularly ranks in the top 10 most popular social-networking apps and in the top 25 across all apps in terms of daily active users.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: